Adaptive Clinical Systems and the Medisanté Group AG have teamed to allow sponsors, biotechs, and CROs the flexibility to integrate a variety of digitally enabled medical devices with any EDC to enable blind measurement data at the patient source in pursuit of clinical trial research data.
SARASOTA, Fla., April 27, 2023 /PRNewswire-PRWeb/ -- Adaptive Clinical Systems and the Medisanté Group AG have teamed to allow sponsors, biotechs, and CROs the flexibility to integrate a variety of digitally enabled medical devices with any EDC to enable blind measurement data at the patient source in pursuit of clinical trial research data. The data integration solution expands the Medisanté Group M+ Hub zero touch configuration for patients with the Adaptive eClinical Bus for data interoperability, adding the capability to integrate with eClinical tools that are vendor agnostic. The solution adds connectivity for multiple devices today via the Medisanté M+ Hub with Adaptive Clinical Systems reach of clinical research data from roughly 90 percent of available eClinical tools.
Benefits from the clinical research data solutions:
- Provide a universal solution for decentralized clinical trials (DCTs) for biomarkers and vital signs
- Give the Sponsor the ability to capture vital signs and biomarkers regardless of device manufacturer
- Enable IoT device and fleet management including cellular-enabled medical devices and cellular enabled gateway with auto-paired Bluetooth medical devices
- Capture source measurement data in full compliance with HIPAA, GDPR and CCPA
"The M+ hub enables fully digitally inclusive self-measurement at home thereby facilitating unbiased data collection especially for chronic disease studies which are often at risk from bias associated with SDoH." said Gilles Lunzenfichter, CEO of Medisanté Group, "The combination of the Adaptive eClinical Bus & DataVIEW with M+ hub will greatly simplify data capture pathways and enrich oversight capabilities."
"For clinical research companies that are experiencing a lack of integration, unification, or standardization of IoT technological tools, this solution removes the data silos created when the patient is the source," said Sina Adibi, President and CEO, Adaptive Clinical System. "Decentralized clinical trials continue to challenge the clinical research community. By enabling the Adaptive eClinical Bus with the Medisanté M+ Hub for IoT medical devices, sponsors and CROs will improve their data streams with this device and EDC agnostic solution."
For more information, please see the company websites: https://www.medisante-group.com/ and https://adaptive-clinical.com
About Adaptive Clinical Systems
Adaptive Clinical Systems, a global life sciences technology company, provides the leading data integration platform for clinical research. With the Adaptive eClinical Bus® and Adaptive DataVIEW®, see how your clinical trial data is transformed with data in motion. Adaptive Clinical's solutions enable data streams across all study partners and eClinical eSources. Whether your challenge is data visualization, API integrations or data integration, our solutions help remove data islands and silos. We make your data actionable faster. For more information, please see Adaptive Clinical System website: http://www.adaptive-clinical.com.
About Medisanté Group
Medisanté Group enables the hospital at home with global medical IoT by keeping the device experience seamless and secure at scale in care and research. M+ Hub is the 1st global medical IoT cloud infrastructure that connects and manages over a global private cellular network a growing range of devices that are provisioned by research teams and requires no configuration by subjects.
Media Contact
Mitch Collins, Adaptive Clinical Systems, 1 856-473-4370, [email protected]
Andrew Barker, Medisanté Group AG, 21 7914920, [email protected]
SOURCE Adaptive Clinical Systems
Share this article